COVID-19 Updates
From the Journals
Antidepressant may help COVID-19 patients avoid serious illness
Racetrack workers who developed COVID-19 and took a 2-week course of fluvoxamine did not have to be hospitalized and felt better after 2 weeks.
Latest News
New campaign fights COVID-19 vaccine disinformation
The spread of COVID-19 vaccine misinformation creates “a really powerful parallel pandemic to the real pandemic.”
From the Journals
COVID-19: Another study links colchicine to better results
Brazilian trial tested gout drug against placebo in hospitalized patients.
Feature
U.S. COVID-19 death toll passes 450,000
Conference Coverage
Delusional infestation surges during COVID-19 pandemic
Experts weigh in on management of this challenging disorder marked by tenacious false beliefs.
Feature
The Match and COVID-19: Stolen interviews, swag bags, and stress
“It’s really hard to get a real feel for the program when you’ve not been there in person.”
From the Journals
Microthrombi, necrosis seen in COVID-19 hearts on autopsy
A new autopsy series shows microthrombi and focal necrosis in hearts of patients who died of COVID-19. The findings support use of anticoagulation...
News
New NIH database will track neurologic effects of COVID-19
The NeuroCOVID Project will collect deidentified patient information about new neurological issues that coincide with their COVID disease or...
Feature
J&J vaccine 85% efficacious against severe COVID globally
The efficacy against severe disease provided by the Janssen/J&J vaccine held true regardless of age, race/ethnicity, absence or presence of...
Feature
Rapid shifts in radiotherapy for cancer in response to COVID-19
Some radiotherapy regimens were shortened, but others were intensified, suggesting that they were being used as a replacement for surgery.
Feature
‘Category 5’ COVID hurricane approaches, expert says